Physician profile
Daniel Duelm
NPI 1023099314
$458.81
in general payments reported to CMS, 2019-2025
11 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.77 · 2023: $109 · 2024: $112 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $173.82 | 2025 | |
| Ermi LLC | $81.52 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $57.46 | 2023-2024 | Euflexxa |
| Fidia Pharma USA INC. | $36.33 | 2023-2024 | Hymovis, Triluron |
| Davol INC. | $17.22 | 2025 | Arista |
| Bioventus LLC | $16.85 | 2025 | Xcell |
| Solventum Corporation | $16.55 | 2024 | V.A.C.Instill, Prevena |
| Zimmer Biomet Holdings, INC. | $15.83 | 2022 | |
| Depuy Synthes Sales INC. | $14.94 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.94 | 2023 | |
| Sanara Medtech INC. | $13.35 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Duelm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.